| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $107.9M | — | -1.4% |
| Cost of Revenue | $29.2M | — | +7.7% |
| Gross Profit | $78.7M | — | -4.4% |
| R&D Expense | $21.5M | — | -1.9% |
| SG&A Expense | $22.3M | — | -3.9% |
| Operating Income | $5.6M | — | +399.3% |
| Pre-tax Income | $3.1M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $91.9M | -40.4% | -20.1% |
| Accounts Receivable | $70.4M | -41.6% | -1.5% |
| Current Assets | $208.0M | -34.6% | -15.8% |
| Total Assets | $499.5M | -19.7% | -12.7% |
| Current Liabilities | $263.6M | -11.2% | -19.4% |
| Long-term Debt |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $37.4M | — | -0.8% |
| Capital Expenditures | $429K | — | -23.7% |
| Investing Cash Flow | -$429K | — | +97.8% |
| Financing Cash Flow | -$100.1M | — | -244.8% |
| Free Cash Flow | $37.0M | — | -0.4% |
| +306.1% |
| Income Tax | $433K | — | +2647.1% |
| Net Income | $2.6M | — | +240.9% |
| EPS (Basic) | $0.02 | — | +100.0% |
| EPS (Diluted) | $0.02 | — | +100.0% |
| $147.6M |
| +50.7% |
| — |
| Total Liabilities | $475.0M | +2.7% | +10.4% |
| Stockholders' Equity | $24.5M | -84.6% | -82.8% |